Arash Alborzi, MD
Infectious Disease · Glendale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 31 years
- Graduated 1995
Offices
1 location · Arash Alborzi MD Inc · 6 clinicians in this group
Hospitals listed: Glendale Adventist Medical Center · Hollywood Presbyterian Medical Center · Monterey Park Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Alborzi’s office at (818) 550-1998 to ask if they take your plan before you enroll.
California Medical Board record
Licence A89523 · Current
Licensed to practise in California · since 2004 · expires 2028-05-31 · Shiraz University Faculty of Medicine Aka Pahlavi University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Glendale Adventist Medical CenterGlendale, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.57) · 9,330 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.073, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.277, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- Hollywood Presbyterian Medical CenterLos Angeles, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.016, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.165, Oct 2024 – Sep 2025
- Monterey Park HospitalMonterey Park, CAAcute Care Hospital · Proprietary · No emergency departmentPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Glendale Adventist Medical Center
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 0 better, 6 the same, 3 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.57) · 9,330 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.073 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.277 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0.01 to 1.79) · 1,817 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.75 (0.48 to 1.01) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 161.81 (119.07 to 204.55) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 70 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7 · 142 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 312 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.7 · 787 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.9 · 1,340 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 352 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,776 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 11,108 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.18 (0 to 0.35) · 11,736 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3 (1.22 to 4.78) · 2,564 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.76 (0.19 to 3.33) · 882 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.38 (0.04 to 2.71) · 2,540 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.3 (2.34 to 14.26) · 947 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.26 (1.99 to 8.53) · 895 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 112 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.686 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.978 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.234 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.7 · 368 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.2 · 930 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 30.6 · 370 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -4.5 · 1,036 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30.9 · 1,549 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.9 · 1,397 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (7.5 to 15.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.9 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.4 · 68 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 171 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.5) · 183 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 416 cases | No different | Jan 2024 – Dec 2024 |
What patients said (759 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 66% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Hollywood Presbyterian Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 3 better, 4 the same, 0 worse of 7 measures. Readmissions: 1 better, 5 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.016 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.165 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.92 (0 to 1.95) · 687 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.51 to 1.21) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 140.36 (84.45 to 196.27) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.7 · 187 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 289 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.9 · 1,577 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.39) · 3,875 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.11 to 0.51) · 3,998 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.09 (1.83 to 6.36) · 761 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.29) · 396 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (0.67 to 3.87) · 834 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.18 (0 to 14.44) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.49 (1.39 to 9.58) · 287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.68 (0.18 to 3.18) · 172 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.04) · 3,450 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 209 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.363 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 124 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 304 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17.4 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 22.2 · 231 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 40.9 · 284 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 331 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 200 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 106 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.3 to 16.8) · 72 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1.2) · 137 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,225 patients answered, 24% of those asked)
| Cleanliness | 2 |
| Nurse communication | 1 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 66% |
| Doctors "always" communicated well | 69% |
| Staff "always" explained | 50% |
| Yes, staff "did" give patients this information | 79% |
| Yes, staff "did" give patients information about help after discharge | 75% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 67% |
| Doctors "always" treated them with courtesy and respect | 75% |
| Patients who gave a rating of "9" or "10" (high) | 58% |
| Staff "always" explained new medications | 66% |
| Nurses "always" explained things so they could understand | 62% |
| Nurses "always" listened carefully | 63% |
| Nurses "always" treated them with courtesy and respect | 73% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 35% |
| Yes, staff "did" give patients information about possible symptoms | 82% |
See every measure and the patient survey for Monterey Park Hospital
Behind the star rating — Deaths: 0 better, 3 the same, 0 worse of 3 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 222 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.91 (0.46 to 1.37) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 16.5 · 41 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.7 · 548 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 976 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 1,025 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.31 (0.74 to 5.88) · 150 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.67 (0 to 3.41) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.56 (0.86 to 4.26) · 149 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.19 (0 to 19.27) · 29 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (0.88 to 9.56) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.28) · 37 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.4 (0 to 1.47) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 37 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.4 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 19.3 · 37 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 30 · 86 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 30 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 16.9) · 108 cases | No different | Jan 2022 – Dec 2024 |
What patients said (326 patients answered, 13% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 68% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 81% |
| Yes, staff "did" give patients information about help after discharge | 76% |
| Doctors "always" explained things so they could understand | 64% |
| Doctors "always" listened carefully | 66% |
| Doctors "always" treated them with courtesy and respect | 73% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 66% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 77% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$634,687
Medicare paid this office $634,687 for 929 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 847 | $516,742 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 543 | $86,600 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 191 | $25,453 | $65 |
| Initial hospital care with same-day admission and discharge with high level of medical decision making, per day at least 85 minutes | 15 | $2,730 | $171 |
Who their Medicare patients are
929 Original Medicare patients in 2024. Average age 78 · Under 65 9% · 85 and older 32% · Women 50% · Also on Medicaid 84% · Health risk score 3.79. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Diabetes 71% · Coronary heart disease 67% · Heart failure 67% · Chronic kidney disease 64% · Depression 51% · Dementia 48% · Atrial fibrillation 46% · COPD 43% · Stroke 27% · Cancer 20%.
The office billed $2,203,580, Medicare allowed $797,560 and paid $634,687; for 6,353 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 929 | 6,353 | 78 | 3.79 | $2,203,580 | $634,687 |
| 2023 | 1,055 | 9,678 | 78 | 3.47 | $3,420,430 | $1,004,284 |
| 2022 | 932 | 5,286 | 78 | 3.25 | $1,913,910 | $510,807 |
| 2021 | 772 | 3,369 | 77 | 3.41 | $1,164,545 | $317,684 |
| 2020 | 1,254 | 8,347 | 76 | 3.64 | $2,530,200 | $698,482 |
| 2019 | 1,172 | 8,118 | 76 | 4.05 | $2,896,935 | $796,667 |
| 2018 | 1,214 | 9,132 | 77 | 3.80 | $3,151,605 | $870,565 |
| 2017 | 1,316 | 13,412 | 77 | 3.59 | $4,280,090 | $1,176,589 |
| 2016 | 1,316 | 15,158 | 76 | 3.69 | $4,696,775 | $1,286,513 |
| 2015 | 1,004 | 11,234 | 77 | 3.38 | $3,463,595 | $938,397 |
| 2014 | 866 | 9,416 | 77 | 3.72 | $3,003,585 | $811,187 |
| 2013 | 914 | 11,118 | 77 | 3.61 | $3,793,475 | $994,090 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 990 | $844,114 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 810 | $146,585 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 92 | $10,805 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,415 | $109 |
2022: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 838 | $387,220 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 607 | $116,997 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $6,127 | $60 |
2021: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 636 | $215,153 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 384 | $68,994 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 238 | $31,473 | $61 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $1,976 | $116 |
2020: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 849 | $288,308 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 778 | $239,990 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 798 | $153,479 | $173 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 135 | $15,906 | $115 |
2019: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 1,064 | $618,824 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 838 | $171,087 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $5,058 | $62 |
2018: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 1,044 | $616,381 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 849 | $172,595 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 305 | $61,833 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 160 | $19,020 | $115 |
2017: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 1,138 | $690,549 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 874 | $245,373 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 838 | $171,358 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 522 | $66,446 | $115 |
2016: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 1,148 | $663,817 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 951 | $358,466 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 912 | $200,646 | $171 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 431 | $52,092 | $114 |
| Long return visit (40+ min) | 24 | $3,994 | $125 |
| Return visit (30+ min) | 27 | $3,597 | $86 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,029 | $73 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 910 | $534,177 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 650 | $237,408 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 568 | $108,742 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 392 | $48,123 | $112 |
| Return visit (30+ min) | 26 | $3,993 | $89 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,530 | $85 |
2014: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 746 | $507,998 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 555 | $152,026 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 530 | $108,999 | $168 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 295 | $37,566 | $113 |
| Return visit (30+ min) | 12 | $1,471 | $92 |
| Long return visit (40+ min) | 11 | $1,358 | $113 |
| Short return visit (20+ min) | 13 | $1,278 | $61 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 819 | $761,565 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 773 | $162,485 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 282 | $49,956 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 136 | $16,503 | $109 |
| Short return visit (20+ min) | 13 | $1,299 | $62 |
Medicaid work
$78,827 in 2024
Medicaid paid $78,827 for 3,138 billed services this clinician did in 2024, up to 70 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 2,759 | $63,863 |
| 1ST HOSP IP/OBS HIGH 75 | 321 | $14,888 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 58 | $76 |
| 2024 | 3,138 | 3 | 70 | $78,827 |
| 2023 | 6,047 | 2 | 98 | $210,370 |
| 2022 | 5,682 | 2 | 95 | $219,170 |
| 2021 | 7,686 | 3 | 198 | $345,673 |
| 2020 | 10,558 | 5 | 173 | $377,017 |
| 2019 | 8,170 | 3 | 146 | $238,071 |
| 2018 | 6,403 | 4 | 105 | $134,412 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 5,363 | $168,136 |
| 1ST HOSP IP/OBS HIGH 75 | 684 | $42,233 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 5,003 | $170,994 |
| 1ST HOSP IP/OBS HIGH 75 | 679 | $48,176 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 6,730 | $254,963 |
| 1ST HOSP IP/OBS HIGH 75 | 924 | $86,577 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 32 | $4,132 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 8,250 | $266,870 |
| 1ST HOSP IP/OBS HIGH 75 | 1,420 | $96,134 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 838 | $13,363 |
| 1ST HOSPITAL IP/OBS CARE MODERATE MDM 55 MINUTES | 17 | $575 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 33 | $75 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 6,845 | $166,911 |
| 1ST HOSP IP/OBS HIGH 75 | 1,256 | $71,080 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 69 | $80 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 5,132 | $103,537 |
| 1ST HOSP IP/OBS HIGH 75 | 815 | $28,533 |
| Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 253 | $2,267 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 203 | $76 |
Drugs they prescribed that Part D paid
$61,658
Pharmacies billed $61,658 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 231) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
209 generic and 22 brand-name prescriptions · $61,658 in drug cost · 207 antibiotic prescriptions to 101 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Daptomycin | 19 | $29,194 | $1,537 |
| Ertapenem | 17 | $9,181 | $540 |
| Ceftriaxone | 29 | $3,269 | $113 |
| Vancomycin | 18 | $1,574 | $87 |
| Cefazolin | 17 | $516 | $30 |
See all 6 drugs
| Daptomycin | 19 | $29,194 | $1,537 |
| Ertapenem | 17 | $9,181 | $540 |
| Ceftriaxone | 29 | $3,269 | $113 |
| Vancomycin | 18 | $1,574 | $87 |
| Cefazolin | 17 | $516 | $30 |
| Amoxicillin-Clavulanate Potass | 24 | $126 | $5 |
Year by year
| 2024 | 231 | 105 | 0% (0) | 10% | $61,658 |
| 2023 | 288 | 122 | 0% (0) | None | $102,313 |
| 2022 | 215 | 111 | 0% (0) | None | $56,378 |
| 2021 | 179 | 75 | None | None | $62,844 |
| 2020 | 172 | 90 | 0% (0) | 10% | $29,078 |
| 2019 | 180 | 93 | None | 13% | $49,740 |
| 2018 | 218 | 109 | 0% (0) | 11% | $41,089 |
| 2017 | 230 | 96 | 0% (0) | 24% | $58,489 |
| 2016 | 187 | 60 | 0% (0) | 28% | $54,031 |
| 2015 | 276 | 108 | None | 18% | $60,686 |
| 2014 | 299 | 105 | None | None | $76,762 |
| 2013 | 249 | 93 | None | 35% | $90,073 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Daptomycin | 16 | $21,658 | $1,354 |
| Ertapenem | 28 | $20,653 | $738 |
| Vancomycin | 48 | $4,899 | $102 |
| Ceftriaxone | 26 | $2,607 | $100 |
| Sodium Chloride | 12 | $498 | $42 |
| Ciprofloxacin | 15 | $175 | $12 |
| Cephalexin | 14 | $169 | $12 |
| Amoxicillin-Clavulanate Potass | 18 | $154 | $9 |
2022: 7 drugs
| Ertapenem | 21 | $14,960 | $712 |
| Vancomycin | 18 | $3,634 | $202 |
| Cephalexin | 18 | $196 | $11 |
| Amoxicillin-Clavulanate Potass | 20 | $131 | $7 |
| Metronidazole | 14 | $96 | $7 |
| Ciprofloxacin | 16 | $80 | $5 |
| Levofloxacin | 13 | $55 | $4 |
2021: 4 drugs
| Ertapenem | 15 | $10,523 | $702 |
| Vancomycin | 17 | $2,794 | $164 |
| Amoxicillin-Clavulanate Potass | 23 | $228 | $10 |
| Cephalexin | 11 | $60 | $5 |
2020: 6 drugs
| Ertapenem | 12 | $10,052 | $838 |
| Vancomycin | 17 | $1,740 | $102 |
| Cefepime | 11 | $914 | $83 |
| Ceftriaxone | 12 | $369 | $31 |
| Amoxicillin-Clavulanate Potass | 27 | $286 | $11 |
| Levofloxacin | 11 | $74 | $7 |
2019: 4 drugs
| Ertapenem | 15 | $9,176 | $612 |
| Vancomycin | 23 | $3,753 | $163 |
| Amoxicillin-Clavulanate Potass | 15 | $162 | $11 |
| Cephalexin | 15 | $103 | $7 |
2018: 9 drugs
| Invanz | 13 | $11,465 | $882 |
| Vancomycin | 25 | $4,700 | $188 |
| Levofloxacin | 13 | $226 | $17 |
| Clindamycin | 16 | $209 | $13 |
| Metronidazole | 14 | $188 | $13 |
| Ciprofloxacin | 14 | $144 | $10 |
| Cephalexin | 20 | $111 | $6 |
| Amoxicillin-Clavulanate Potass | 11 | $69 | $6 |
| Amoxicillin | 12 | $35 | $3 |
2017: 5 drugs
| Invanz | 27 | $21,163 | $784 |
| Vancomycin | 33 | $4,149 | $126 |
| Levofloxacin | 22 | $264 | $12 |
| Azithromycin | 13 | $212 | $16 |
| Metronidazole | 13 | $157 | $12 |
2016: 3 drugs
| Invanz | 24 | $18,707 | $779 |
| Vancomycin | 21 | $2,656 | $126 |
| Sodium Chloride | 12 | $801 | $67 |
2015: 9 drugs
| Rifabutin | 15 | $13,391 | $893 |
| Vancomycin | 14 | $4,778 | $341 |
| Ethambutol | 15 | $1,668 | $111 |
| Valacyclovir | 18 | $503 | $28 |
| Levofloxacin | 29 | $252 | $9 |
| Azithromycin | 17 | $236 | $14 |
| Metronidazole | 15 | $196 | $13 |
| Cephalexin | 14 | $127 | $9 |
| Clindamycin | 18 | $117 | $6 |
2014: 9 drugs
| Cubicin | 11 | $14,396 | $1,309 |
| Invanz | 14 | $8,490 | $606 |
| Vancomycin | 21 | $6,778 | $323 |
| Ethambutol | 13 | $1,250 | $96 |
| Sodium Chloride | 13 | $711 | $55 |
| Azithromycin | 14 | $424 | $30 |
| Levofloxacin | 24 | $328 | $14 |
| Amox Tr-Potassium Clavulanate | 15 | $194 | $13 |
| Cephalexin | 18 | $178 | $10 |
2013: 7 drugs
| Cubicin | 20 | $40,791 | $2,040 |
| Mycobutin | 15 | $13,382 | $892 |
| Invanz | 19 | $7,199 | $379 |
| Ethambutol | 18 | $1,678 | $93 |
| Azithromycin | 17 | $601 | $35 |
| Levofloxacin | 14 | $136 | $10 |
| Sulfamethoxazole-Trimethoprim | 13 | $78 | $6 |
Money from drug and device companies
$319 in 2025
| 2025 | 3 | 5 | None | $319 |
| 2024 | 3 | 4 | None | $77 |
| 2022 | 1 | 1 | None | $23 |
| 2021 | 1 | 1 | None | $140 |
| 2020 | 2 | 5 | None | $94 |
| 2019 | 1 | 20 | None | $208 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Emblaveo | $246 | 2 payments
|
| Gilead Sciences | None | $48 | 2 payments
|
| Melinta Therapeutics | Rezzayo | $25 | 1 payment
|
See all 5 published payments
| Abbvie | Meals · 2025-08-14 | Emblaveo | $125 |
| Gilead Sciences | Meals · 2025-06-25 | None | $26 |
| Gilead Sciences | Meals · 2025-03-25 | None | $22 |
| Melinta Therapeutics | Meals · 2025-02-03 | Rezzayo | $25 |
| Abbvie | Meals · 2025-01-31 | Teflaro | $121 |
See earlier years (2024, 2022, 2021, 2020, 2019)
2024: $77
| Melinta Therapeutics | Rezzayo | $31 | 2 payments
|
| Gilead Sciences | None | $25 | 1 payment
|
| Boston Scientific | Bodyguardian | $21 | 1 payment
|
2022: $23
| Abbvie | Avycaz | $23 | 1 payment
|
2021: $140
| Cumberland Pharmaceuticals | Vibativ | $140 | 1 payment
|
2020: $94
| Allergan | Dalvance | $76 | 4 payments
|
| Merck Sharp & Dohme | Zerbaxa | $18 | 1 payment
|
2019: $208
| Allergan | Avycaz | $208 | 20 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 78.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1770582165
- Licence
- CA A89523California A89523: Current · expires 2028-05-31
- Group
- Arash Alborzi MD Inc
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- Po Box 29159, Los Angeles, CA, 90029
- NPI first listed
- 2005-07-18
- NPI last updated
- 2020-03-03
- NPI record certified
- 2020-03-03
This is when the NPI record was last certified, not a medical board exam.